TP53 and neoplasm: ID8-p53−/−Brca2−/− tumours may have differences in the extracellular matrix, vascularization, or in cytokine/chemokine expression, thereby limiting immune cell infiltration into the tumour74 since more activated DCs and T cells were observed systemically, i.e. in the spleen of tumour-bearing mice.